Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2014 by Sidney Kimmel Comprehensive Cancer Center.
Recruitment status was  Active, not recruiting
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: August 7, 2008
Last updated: October 1, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):